RxDoctor Payments Data

Justen Bickett, APRN

Family · Owensboro, KYNPI 1033657895

Payments from drug & device makers

$4,579in general payments, 2019–2025

Across 301 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$858
  • AbbVie$602
  • Lilly USA, LLC$501
  • Pfizer$288
  • Amgen$166
  • Otsuka America Pharmaceutical, Inc.$144
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$4,579100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,579 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$69,209
Medicare patients
289
Services billed
907

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide91$94,662
FarxigaDapagliflozin Propanediol61$29,938
JardianceEmpagliflozin59$24,743
Nurtec OdtRimegepant Sulfate23$21,974
EliquisApixaban20$21,915
TrulicityDulaglutide24$19,079
TradjentaLinagliptin14$16,191
GemtesaVibegron42$14,991
LinzessLinaclotide19$11,664
Bydureon BciseExenatide Microspheres13$10,581
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen293$6,751
MounjaroTirzepatide15$6,430
JanuviaSitagliptin Phosphate13$4,560
VascepaIcosapent Ethyl13$4,488
Gabapentin250$3,410

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$858$94,66291 claims
PfizerNurtec Odt, Eliquis$288$43,88943 claims
Boehringer IngelheimJardiance, Tradjenta$140$40,93473 claims
AstraZenecaFarxiga$66$29,93861 claims
Lilly USA, LLCTrulicity, Mounjaro$501$25,50839 claims
Sumitomo Pharma America, Inc.Gemtesa$83$14,99142 claims
AbbVieLinzess$602$11,66419 claims
MerckJanuvia$26$4,56013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.

Other family in Owensboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →